Adrenocorticotropic hormone: an effective "natural" biologic therapy for acute gout?

Daoussis, Dimitrios; Bogdanos, Dimitrios P.; Dimitroulas, Theodoros; Sakkas, Lazaros; Andonopoulos, Andrew P.

Treatment of acute gout consists of non-steroidal anti-inflammatory drugs (NSAIDs), colchicine and steroids. However, the typical patient with gout has multiple comorbidities such as cardiovascular disease, hypertension, renal dysfunction or diabetes/metabolic syndrome that represent contraindications to these therapeutic options. The aim of this study is to review the available evidence regarding the use of ACTH as an alternative therapeutic option for acute gout and explore potential mechanisms of action. We performed an electronic search (MEDLINE, Scopus and Web of Science) using the keywords ACTH or adrenocorticotropic hormone combined with gout or crystal-induced arthritis. ACTH appears suitable for patients with many comorbidities due to its good safety profile. Clinical evidence shows that ACTH is at least as effective as classic agents. The mechanism of action of ACTH in gout is not entirely known. Robust experimental evidence points to the direction that ACTH does not act solely by triggering the release of endogenous steroids but also appears to downregulate inflammatory responses by activating melanocortin receptors on innate immune cells, such as macrophages. Moreover, indirect evidence indicates that ACTH may have an IL-1 antagonistic effect. We propose that ACTH may be an alternative therapeutic option for gout in patients with multiple comorbidities. Large-scale studies assessing the efficacy and safety of ACTH compared to classic therapeutic options are needed.

ADRENOCORTICOTROPIC hormone; GOUT; INFLAMMATION; MELANOCORTIN receptors; ANTI-inflammatory agents

Rheumatology International, 2020, Vol 40, Issue 12, p1941

0172-8172

Academic Journal

10.1007/s00296-020-04659-5